Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer-Reference-Cited by-同舟云学术

Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer

Published:2022-08 Issue:2 Volume:208 Page:309-316
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Perera Marlon¹^ORCID,Assel Melissa J.²,Benfante Nicole E.²,Vickers Andrew J.²,Reuter Victor E.³,Carlsson Sigrid¹²⁴,Laudone Vincent¹,Touijer Karim A.¹,Eastham James A.¹,Scardino Peter T.¹,Fine Samson W.³,Ehdaie Behfar¹

Affiliation:

1. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

4. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002685

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance;Clinical Genitourinary Cancer;2024-12

2. Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study;European Urology Open Science;2024-10

3. Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2–4 Prostate Cancer;European Urology;2024-07

4. PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy;American Journal of Roentgenology;2023-12-13

5. Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients;Cancers;2023-11-17